Found 6 matching trials
Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia PHASE2 This study is designed to assess the efficacy, safety, and tolerability of ...
Show More Location
89Bio Clinical Study Site
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) PHASE3 The study will assess the efficacy and safety of 2 dose regimens of pegozaf...
Show More Location
89bio Clinical Study Site
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH PHASE3 The study will assess the efficacy and safety of pegozafermin administered ...
Show More Location
89bio Clinical Study Site
Learn More & Join Trial
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia PHASE3 To determine the effect of Pegozafermin on fasting serum triglyceride level...
Show More Location
89bio Clinical Study Site
Learn More & Join Trial
A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH PHASE1 Part 1: This is a multi-center evaluation of pegozafermin (administered wee...
Show More Location
89bio Clinical Study Site
Learn More & Join Trial
Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) PHASE2 This is a randomized, double-blind, placebo-controlled study that will eval...
Show More Location
89bio Clinical Study Site
Learn More & Join Trial